MedPath

Estudio piloto de 24 semanas, doble-ciego aleatorizado, paralelo, controlado con placebo de memantina y terapia del lenguaje restringida en las afasias post-ictus: correlación de los cambios neurofisiológicos con potenciales evocados cognitivos durante la recuperación

Conditions
AFASIA SECUNDARIA A ACCIDENTES CEREBRO-VASCULARES
Registration Number
EUCTR2004-002337-39-ES
Lead Sponsor
Gabinete Berthier y Martínez, S.L.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: ;Secondary Objective: ;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath